Ignite Creation Date:
2025-12-25 @ 2:06 AM
Ignite Modification Date:
2026-05-18 @ 1:05 PM
Study NCT ID:
NCT01729260
Status:
COMPLETED
Last Update Posted:
2021-05-07
First Post:
2012-11-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Mebendazole in Newly Diagnosed High-Grade Glioma Patients Receiving Temozolomide
Sponsor:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
J1194
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |